Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion

Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion

Abstract Introduction To investigate treatment outcomes after switching from ranibizumab to aflibercept intravitreal injections in patients with macular oedema (MO) secondary to branch retinal vein occlusion (BRVO). Methods Eligible patients with refractory MO secondary to BRVO, post treatment with...

Full description

Bibliographic Details
Main Authors: Vasileios E. Konidaris, Konstantinos T. Tsaousis, Rossella Anzidei, Guillermo de la Mata, Alexander J. Brent
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-10-01
Series:Ophthalmology and Therapy
Subjects:
Aflibercept
Anti-VEGF
Branch retinal vein occlusion
Ranibizumab
Switching
Online Access:http://link.springer.com/article/10.1007/s40123-018-0149-3

Internet

http://link.springer.com/article/10.1007/s40123-018-0149-3

Similar Items